Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 Fast-growings companies in Monoclonal antibody
by Most Patent Filing In 1 Year in the Switzerland in 2020

The Monoclonal antibody top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Patent Filing In 1 Year Monoclonal antibody Fast-growings in the Switzerland. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2020, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Monoclonal antibodies (mAb or moAb) are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal antibodies bind to multiple epitopes and are usually made by several different plasma cell (antibody secreting immune cell) lineages. Bispecific monoclonal antibodies can also be engineered, by increasing the therapeutic targets of one single monoclonal antibody to two epitopes.
#
Company Name
Region
Tech Topics
Total
1
Novartis AG
Dosage form,Health care,Medicine,
...[+2]
Patent: 28
2
F. Hoffmann-La Roche Ltd.
Medicine,Health care,Drug,
...[+2]
Patent: 13
3
Novimmune SA
Monoclonal antibody,Health care,Drug discovery,
...[+2]
Patent: 4
4
Teva Pharmaceuticals International GmbH
Patent: 3
5
AC Immune SA
Pharmacy and Therapeutics,Medicine,Biomedicine,
...[+2]
Patent: 2
6
University of Zurich
Structural biology,Neuroscience,Public sector,
...[+2]
Patent: 2
7
Alentis Therapeutics AG
Liver disease,Pharmacy and Therapeutics,Cancer
Patent: 1
8
Syngenta AG
Pesticide,Agriculture,Farming industry,
...[+2]
Patent: 1
9
Lonza Ltd.
Pharmacy
Patent: 1
10
Syngenta Participations AG
Patent: 1
Page generation time: Jul 20 2025